PharmaCyte Biotech, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
PharmaCyte Biotech, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • PharmaCyte Biotech, Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 10, 2024 was 7.68M shares, a 12.5% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 7.68M -1.1M -12.5% Sep 10, 2024 10-Q 2024-09-17
Q2 2024 7.71M -1.07M -12.2% Aug 8, 2024 10-K 2024-08-13
Q1 2024 8.46M -8.98M -51.5% Mar 15, 2024 10-Q 2024-03-18
Q4 2023 8.62M -10.1M -54% Dec 13, 2023 10-Q 2023-12-15
Q3 2023 8.78M -12M -57.7% Sep 18, 2023 10-Q 2023-09-18
Q2 2023 8.78M -12M -57.7% Jul 31, 2023 10-K 2023-07-31
Q1 2023 17.4M -3.28M -15.8% Mar 16, 2023 10-Q 2023-03-16
Q4 2022 18.7M -1.99M -9.6% Dec 14, 2022 10-Q 2022-12-14
Q3 2022 20.8M +35K +0.17% Sep 14, 2022 10-Q 2022-09-14
Q2 2022 20.7M +19.1M +1187% Jul 28, 2022 10-K 2022-07-28
Q1 2022 20.7M -2.36B -99.1% Mar 15, 2022 10-Q 2022-03-15
Q4 2021 20.7M -2.31B -99.1% Dec 14, 2021 10-Q 2021-12-14
Q3 2021 20.7M -2.31B -99.1% Sep 14, 2021 10-Q 2021-09-14
Q2 2021 1.61M -2.33B -99.9% Aug 9, 2021 10-K 2021-08-10
Q1 2021 2.39B +904M +61% Mar 12, 2021 10-Q 2021-03-12
Q4 2020 2.33B +943M +67.7% Dec 11, 2020 10-Q 2020-12-11
Q3 2020 2.33B +1.01B +75.7% Sep 11, 2020 10-Q 2020-09-11
Q2 2020 2.33B +1.01B +75.7% Aug 11, 2020 10-K 2020-08-13
Q1 2020 1.48B +355M +31.5% Mar 13, 2020 10-Q 2020-03-13
Q4 2019 1.39B +265M +23.5% Dec 20, 2019 10-Q 2019-12-23
Q3 2019 1.33B +249M +23% Sep 12, 2019 10-Q 2019-09-13
Q2 2019 1.33B +287M +27.6% Aug 12, 2019 10-K 2019-08-13
Q1 2019 1.13B +114M +11.2% Mar 14, 2019 10-Q 2019-03-14
Q4 2018 1.13B +153M +15.7% Dec 14, 2018 10-Q 2018-12-14
Q3 2018 1.08B +106M +10.9% Sep 12, 2018 10-Q 2018-09-12
Q2 2018 1.04B +67.9M +6.97% Jul 20, 2018 10-K 2018-07-20
Q1 2018 1.01B +138M +15.8% Mar 19, 2018 10-Q 2018-03-19
Q4 2017 974M +124M +14.6% Dec 14, 2017 10-Q 2017-12-14
Q3 2017 973M +124M +14.6% Sep 12, 2017 10-Q 2017-09-13
Q2 2017 973M +125M +14.8% Jul 26, 2017 10-K 2017-07-27
Q1 2017 875M +103M +13.4% Mar 13, 2017 10-Q/A 2017-03-13
Q4 2016 850M +99.1M +13.2% Dec 2, 2016 10-Q 2016-12-02
Q3 2016 849M +105M +14.2% Sep 6, 2016 10-Q 2016-09-06
Q2 2016 848M +105M +14.2% Jul 29, 2016 10-K 2016-07-29
Q1 2016 772M +64.3M +9.09% Mar 7, 2016 10-Q 2016-03-08
Q4 2015 751M +51.5M +7.37% Dec 10, 2015 10-Q/A 2016-01-19
Q3 2015 743M +33.4M +4.71% Aug 24, 2015 10-Q/A 2016-01-19
Q2 2015 743M 0 0% Jul 28, 2015 10-K/A 2016-01-19
Q1 2015 708M +69.5M +10.9% Mar 13, 2015 10-Q 2015-03-13
Q4 2014 699M +106M +17.8% Dec 15, 2014 10-Q 2014-12-15
Q3 2014 710M +72.8M +11.4% Sep 15, 2014 10-Q 2014-09-15
Q2 2014 743M +233M +45.6% Jul 28, 2014 10-K 2015-07-29
Q1 2014 638M +179M +38.8% Mar 17, 2014 10-Q 2014-03-17
Q4 2013 593M +148M +33.2% Dec 13, 2013 10-Q 2013-12-16
Q3 2013 637M +213M +50.3% Sep 13, 2013 10-Q 2013-09-16
Q2 2013 510M -7.89M -1.52% Jul 29, 2013 10-K 2013-07-29
Q1 2013 460M +85.3M +22.8% Mar 25, 2013 10-Q 2013-03-26
Q4 2012 446M +69M +18.3% Dec 21, 2012 10-Q 2012-12-26
Q3 2012 424M +70.6M +20% Sep 10, 2012 10-Q 2012-09-19
Q2 2012 518M Aug 13, 2012 10-K 2012-08-14
Q1 2012 374M Mar 20, 2012 10-Q 2012-03-21
Q4 2011 377M Dec 14, 2011 10-Q 2011-12-15
Q3 2011 353M Sep 19, 2011 10-Q/A 2011-09-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.